KATIE HICKEY: Open Payments
NPI 1386423523 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$586 in 33 payments from 14 companies in 2025. Trend: 2023 $74 · 2024 $733 · 2025 $586
Food & beverage: $586
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $145 |
| Ipsen Biopharmaceuticals, Inc | 3 | $59 |
| PFIZER INC. | 4 | $59 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $56 |
| Janssen Biotech, Inc. | 2 | $53 |
| Madrigal Pharmaceuticals | 2 | $50 |
| Phathom Pharmaceuticals, Inc. | 2 | $28 |
| QOL Medical, LLC | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $21 |
| Enterra Medical, Inc. | 1 | $20 |
Products named: IQIRVO, TREMFYA, REZDIFFRA, MAVYRET, RINVOQ, ENTYVIO, CREON, VELSIPITY.
Industry payments across NC — which companies pay providers there.
